The Future in Cannabis. WorldWide.

Tag: Allard v. Canada

Health Canada Meets Federal Court Deadline!

HC-signature v2On August 11 Health Canada (HC) announced that they will meet the court imposed August 24 2016 deadline for revising the Marihuana for Medical Purposes Regulations (MMPR) . The regulations are now called the Access to Cannabis for Medical Purposes Regulations (ACMPR). These new regulations will replace the MMPR as of August 24, 2016, and are being implemented as a result of the Federal Court ruling in the case of Allard v. Canada. Health Canada has issued a fact sheet – http://news.gc.ca/web/article-en.do?nid=1110409 – with the complete set of regulations to be published on the HC website August 24, 2016.

Read more

Federal Court Ruling Not Appealed!

Minister PhilpotToday Health Canada Minister Jane Philpott has decided not to appeal Justice Phelan’s decision that requires amendments to the Marihuana for Medical Purposes Regulations (MMPR).

According to the Minister ““We will respect the decision of the federal court and as such we are now in a situation where we have responsibility to address the Marihuana for Medical Purposes Regulations and they will be amended accordingly in order to address the concerns of the court.”

Under Justice Phelan’s decision Health Canada has until mid-August to make those changes to the MMPR.  TheraCann will therefore continue to keep you updated on any proposed specifics of these changes and how they will be implemented.

For a full review of Minister Philpott’s comments please click here.

To learn more about our analysis for Justice Phelan’s decision click here.

CDC new guidelines may open door to Medical Marijuana

CDClogoCDC issues sweeping new guidelines to restrict opioid prescribing

The Centre for Disease Control and Prevention, based in Atlanta Georgia USA, issued new guidelines in an attempt to stem the tide of deaths and overdoses resulting from the consumption of opioids to manage pain.  This family of pharmaceutical drugs prescribed by physicians to treat chronic pain, has long been known for its addictive qualities and high risk of overdose.

“Management of chronic pain is an art and a science. The science of opioids for chronic pain is clear” for the vast majority of patients, the known, serious, and too-often fatal risks far outweigh the unproven and transient benefits, wrote CDC Director Dr. Tom Frieden and Dr. Debra Houry, the director of the CDC’s National Center for Injury Prevention and Control in an essay today in the New England Journal of Medicine.”

Read more

Justice Phelan Allard et. al. v. Her Majesty the Queen

marijuana law_300On Wednesday February 24, 2016, Justice Phelan of the BC Federal Court announced his decision in the matter between Allard, Beemish, Hebert and Davey (the “Plaintiffs”) and the Federal Government (the “Defendant” – Her Majesty the Queen in Right of Canada).

The matter concerned the plaintiffs claim that their Section 7 Charter Rights were violated by the repeal by Health Canada of the Medical Marihuana Access Regulations (“MMAR”), in favour of the Marihuana for Medical Purposes Regulations (“MMPR”), introduced in July 2013.

Read more